The privilege of induction avoidance and calcineurin inhibitors withdrawal in 2 haplotype HLA matched white kidney transplantation

Authors

Zaid Brifkani, Washington University School of Medicine in St. Louis
Daniel C. Brennan, Washington University School of Medicine in St. Louis
Krista L. Lentine, Saint Louis University School of Medicine
Timothy A. Horwedel, Barnes-Jewish Hospital
Andrew F. Malone, Washington University School of Medicine in St. Louis
Rowena Delos Santos, Washington University School of Medicine in St. Louis
Thin Thin Maw, Washington University School of Medicine in St. Louis
Tarek Alhamad, Washington University School of Medicine in St. Louis

Journal

Transplantation Direct

Publication Date

2017

Volume

3

Issue

3

Inclusive Pages

e133

Document Type

Open Access Publication

DOI

10.1097/TXD.0000000000000645

Rights and Permissions

Brifkani Z, Brennan DC, Lentine KL, Horwedel TA, Malone AF, Delos Santos R, Maw TT, Alhamad T. The Privilege of Induction Avoidance and Calcineurin Inhibitors Withdrawal in 2 Haplotype HLA Matched White Kidney Transplantation. Transplant Direct. 2017 Feb 8;3(3):e133. doi: 10.1097/TXD.0000000000000645.

Recommended Citation

Brifkani, Zaid; Brennan, Daniel C.; Lentine, Krista L.; Horwedel, Timothy A.; Malone, Andrew F.; Santos, Rowena Delos; Maw, Thin Thin; and Alhamad, Tarek, "The privilege of induction avoidance and calcineurin inhibitors withdrawal in 2 haplotype HLA matched white kidney transplantation." Transplantation Direct. 3, 3. e133. (2017).
https://digitalcommons.wustl.edu/open_access_pubs/5718